Paula Deen continues to keep diabetes in the spotlight. However she is not alone. Alec Baldwin revealed he is pre-diabetic. According to various media reports, that is the reason he lost 30 pounds since he was diagnosed last May.
The FDA has approved an extended-release version of a combination sitagliptin and metformin (Janumet XR) for adults with type 2 diabetes, reported MedPage Today yesterday, 4 February. Drug manufacturer Merck claims this combination outperforms sitagliptin and metformin alone in A1c goal attainment.
Researchers at Henry Ford Hospital in Detroit have discovered that poorly maintained blood sugar in women can lead to hearing loss.
We all know diabetes is an expensive condition. Doctors agree. In fact, Christen Brownlee reported that type 2 diabetics not on insulin do not necessarily have to monitor their blood sugar. It does little to control blood sugar levels and is not cost effective. Brownlee reports for Health Behavior News Service. Feedback on the article however from physicians and patients indicate that self monitoring is still an important tool as we strive to control those glucose levels.[1]
The Journal of Cancer reported a link between kidney cancer and diabetes. The Journal cited a study in which 25.4% of kidney cancer patients in San Antonio who underwent surgery for clear cell renal cell carcinoma had a history of diabetes.
Indian Country Today reported that Native Americans in the Santa Clara Valley of California are using grant money to purchase Nike Air Native shoes specially created for the wider feet of many Native Americans. The grant is through a Diabetes Prevention Program which is part of a Community Wellness and Outreach program.[2]
The FDA approved Amylin Pharmaceuticals and Alkermes' Bydureon, or exenatide as a once-weekly treatment for type 2 diabetes.
The Institute for Molecular Medicine Finland found that five new genetic that affect levels of amino acids may be biomarkers for type 2 diabetes.[3]
Obese women using Depo-Provera are at a higher risk to develop diabetes, according to a University of Southern California's Keck School of Medicine. Depo-Provera is a birth control injection. [4]
[1]Brownlee, Christen. “For Diabetics Not on Insulin, Self Monitoring Blood Sugar Has No Benefit” Health Behavior News Service. http://www.cfah.org/hbns/archives/getDocument.cfm?documentID=22473Accessed 5 February 2012.
[2]Hansen, Terri. “Changing Diabetic Lives, One Pair of Nikes at a Time” Indian Country Today Media Network. http://indiancountrytodaymedianetwork.com/2012/01/24/changing-diabetic-lives-one-pair-of-nikes-at-a-time-74047#ixzz1lXJuTmhJ. Accessed 5 February 2012.
[3]Scientists identify possible diabetes biomarkers. http://www.diabetes.co.uk/news/2012/Jan/scientists-identify-possible-diabetes-biomarkers-93462624.html. Accessed 5 February 2012
[4]O’Neill, Stephanie. “USC study: Depo-Provera birth control may increase diabetes risk for obese women” KPCC http://www.scpr.org/news/2012/02/01/31079/usc-study-depo-provera-birth-control-may-increase-/. Accessed 5 February 2012.
Comments